News

All News
Array
(
    [0] => WP_Term Object
        (
            [term_id] => 1
            [name] => Contura
            [slug] => contura
            [term_group] => 0
            [term_taxonomy_id] => 1
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 8
            [filter] => raw
            [cat_ID] => 1
            [category_count] => 8
            [category_description] => 
            [cat_name] => Contura
            [category_nicename] => contura
            [category_parent] => 0
            [custom_sort] => 1
) [1] => WP_Term Object ( [term_id] => 41 [name] => Aquamid [slug] => aquamid [term_group] => 0 [term_taxonomy_id] => 41 [taxonomy] => category [description] => [parent] => 0 [count] => 0 [filter] => raw [cat_ID] => 41 [category_count] => 0 [category_description] => [cat_name] => Aquamid [category_nicename] => aquamid [category_parent] => 0 [custom_sort] => 2
) [2] => WP_Term Object ( [term_id] => 11 [name] => Bulkamid [slug] => womens-health [term_group] => 0 [term_taxonomy_id] => 11 [taxonomy] => category [description] => [parent] => 0 [count] => 13 [filter] => raw [cat_ID] => 11 [category_count] => 13 [category_description] => [cat_name] => Bulkamid [category_nicename] => womens-health [category_parent] => 0 [custom_sort] => 3
) [3] => WP_Term Object ( [term_id] => 13 [name] => Arthrosamid [slug] => orthopaedics [term_group] => 0 [term_taxonomy_id] => 13 [taxonomy] => category [description] => [parent] => 0 [count] => 13 [filter] => raw [cat_ID] => 13 [category_count] => 13 [category_description] => [cat_name] => Arthrosamid [category_nicename] => orthopaedics [category_parent] => 0 [custom_sort] => 4
) [4] => WP_Term Object ( [term_id] => 17 [name] => Arthramid Vet [slug] => animal-health [term_group] => 0 [term_taxonomy_id] => 17 [taxonomy] => category [description] => [parent] => 0 [count] => 1 [filter] => raw [cat_ID] => 17 [category_count] => 1 [category_description] => [cat_name] => Arthramid Vet [category_nicename] => animal-health [category_parent] => 0 [custom_sort] => 5
) )
Contura
Aquamid
Bulkamid
Arthrosamid
Arthramid Vet
New study aims to explore further and determine more clearly how a pioneering treatment for knee osteoarthritis works in the NHS
New study aims to explore further and determine more clearly how a pioneering treatment for knee osteoarthritis works in the NHS
Date: 6 September 2023
First clinician in Wales to offer innovative injection to help patients suffering from knee osteoarthritis
First clinician in Wales to offer innovative injection to help patients suffering from knee osteoarthritis
Date: 1 September 2023
Contura Orthopaedics Ltd joins the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner
Contura Orthopaedics Ltd joins the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner
Date: 25 August 2023
First clinic in Scotland to offer innovative injection to help patients suffering from knee osteoarthritis
First clinic in Scotland to offer innovative injection to help patients suffering from knee osteoarthritis
Date: 8 June 2023
Bask-ing in the glory of successful seminar at leading orthopaedic conference with patient outcomes at its heart
Bask-ing in the glory of successful seminar at leading orthopaedic conference with patient outcomes at its heart
Date: 31 May 2023
New 3 year data demonstrates the long-term efficacy of Arthrosamid® (2.5% injectable polyacrylamide hydrogel)
New 3 year data demonstrates the long-term efficacy of Arthrosamid® (2.5% injectable polyacrylamide hydrogel)
Date: 4 April 2023
Olympic great named as new ambassador for medical device innovator Contura Orthopaedics Ltd
Olympic great named as new ambassador for medical device innovator Contura Orthopaedics Ltd
Date: 5 December 2022
Patients gain access to innovative new procedure for treating knee osteoarthritis as HCA UK partners with Contura Orthopaedics
Patients gain access to innovative new procedure for treating knee osteoarthritis as HCA UK partners with Contura Orthopaedics
Date: 20 October 2022
Contura announces new CEO to accelerate future growth
Contura announces new CEO to accelerate future growth
Date: 16 November 2021
Contura sells Bulkamid® to Axonics Modulation Technologies, Inc
Contura sells Bulkamid® to Axonics Modulation Technologies, Inc
Date: 26 February 2021
Bulkamid: one year anniversary of FDA approval in the United States
Bulkamid: one year anniversary of FDA approval in the United States
Date: 28 January 2021
Completion of prospective open label clinical study of Arthrosamid® for knee osteoarthritis
Completion of prospective open label clinical study of Arthrosamid® for knee osteoarthritis
Date: 9 October 2020
Completion of recruitment for a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis.
Completion of recruitment for a multi-center, randomized, controlled clinical study of Arthrosamid® for knee osteoarthritis.
Date: 20 May 2020
Approval of Arthrosamid® <br />
for the treatment of knee osteoarthritis
Approval of Arthrosamid®
for the treatment of knee osteoarthritis
Date: 15 April 2020
Contura expands its commercial efforts to the US<br />
and appoints new US Leadership Team
Contura expands its commercial efforts to the US
and appoints new US Leadership Team
Date: 10 February 2020
FDA approves Bulkamid® in the United States and<br />
is now set for launch in Quarter 1 2020
FDA approves Bulkamid® in the United States and
is now set for launch in Quarter 1 2020
Date: 31 January 2020
Results of Randomised Controlled Trial of Bulkamid® versus Tension-free <br />
Vaginal Tape Published
Results of Randomised Controlled Trial of Bulkamid® versus Tension-free
Vaginal Tape Published
Date: 1 January 2020
Urethral bulking agents to be considered as two distinct<br />
classes: particulate and non-particulate
Urethral bulking agents to be considered as two distinct
classes: particulate and non-particulate
Date: 1 December 2019
Observational multicentered study shows that two thirds of women with <br />
stress urinary incontinence choose Bulkamid® when offered a choice
Observational multicentered study shows that two thirds of women with
stress urinary incontinence choose Bulkamid® when offered a choice
Date: 1 December 2019
Completion of recruitment to a prospective, open-label<br />
clinical investigation of Arthrosamid for knee osteoarthritis<br />
Completion of recruitment to a prospective, open-label
clinical investigation of Arthrosamid for knee osteoarthritis
Date: 17 October 2019
Commencement of a multi-center, randomized, controlled<br />
clinical study of Arthrosamid® for knee osteoarthritis<br />
Commencement of a multi-center, randomized, controlled
clinical study of Arthrosamid® for knee osteoarthritis
Date: 15 June 2019
Acquisition of Manufacturing Facility in Copenhagen, Denmark
Acquisition of Manufacturing Facility in Copenhagen, Denmark
Date: 25 May 2018
Searchlight Pharma Announces Launch of Bulkamid® for Treatment of <br />
Female Stress Urinary Incontinence
Searchlight Pharma Announces Launch of Bulkamid® for Treatment of
Female Stress Urinary Incontinence
Date: 10 May 2018
Speciality European Pharma Limited to rebrand as Contura in order to <br />
consolidate its corporate structure and drive growth
Speciality European Pharma Limited to rebrand as Contura in order to
consolidate its corporate structure and drive growth
Date: 19 January 2018
Contura files Bulkamid PMA
Contura files Bulkamid PMA
Date: 30 July 2017
Speciality European Pharma sells Mitem to Substipharm Limited
Speciality European Pharma sells Mitem to Substipharm Limited
Date: 27 April 2017
Speciality European Pharma signs clinical research agreement with Central <br />
Manchester University Hospitals NHS Foundation Trust for the study of <br />
Bulkamid as a first line treatment for stress urinary incontinence
Speciality European Pharma signs clinical research agreement with Central
Manchester University Hospitals NHS Foundation Trust for the study of
Bulkamid as a first line treatment for stress urinary incontinence
Date: 17 February 2017
Speciality European Pharma extends distribution agreement for Regurin XL <br />
in the United Kingdom
Speciality European Pharma extends distribution agreement for Regurin XL
in the United Kingdom
Date: 20 December 2016
MBO at SEP provides capital to accelerate growth and expansion
MBO at SEP provides capital to accelerate growth and expansion
Date: 1 May 2016
Contura signs clinical research agreement to initiate a randomised controlled <br />
trial of Bulkamid against Tension-free Vaginal Tape
Contura signs clinical research agreement to initiate a randomised controlled
trial of Bulkamid against Tension-free Vaginal Tape
Date: 2 September 2015
Speciality European Pharma licenses distribution rights for Cystistat in <br />
Germany and France
Speciality European Pharma licenses distribution rights for Cystistat in
Germany and France
Date: 1 July 2015
Contura sells veterinary rights to Antematter
Contura sells veterinary rights to Antematter
Date: 30 December 2014
Contura terminates Bulkamid distribution rights with Ethicon
Contura terminates Bulkamid distribution rights with Ethicon
Date: 3 May 2013
Speciality European Pharma acquires Contura A/S
Speciality European Pharma acquires Contura A/S
Date: 30 April 2013

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.